Viehbacher...Really?

Quote
anonymous said:
To be fair, Sanofi was already bungling the patent cliff by the time CV came along. There were plenty of idiots doing nothing but riding the Plavix, Lovenox, Lantau bandwagon. They thought Allegra would never lose protection and it did. They thought no one would characterize Lovenox and they did, they thought they would win on Plavix and discounted someone launching at risk. Paris said none of this would happen and the week US leaders fell in line. Having said all that, Viebacher did nothing to improve things after this, nor have any of his successors.

BIIB will go through a lot of change only to come out the other side looking pretty much the same with a new cast of characters at the helm.
Click to expand...

Basically Biogen hired someone to do the slaying..
 












Let's not forget How Viehbacher did a hostile takeover of Gensyme and severely overpaid for it. Raises were basically 1-2.5% per year if you were in top 3% of company. Bonuses were gutted , expense reports were scrutinized for every penny and layoffs kicked into full gear with The Smiling Killer. This is the worst thing that possibly could happen to Biogen.
 






anonymous said:
Let's not forget How Viehbacher did a hostile takeover of Gensyme and severely overpaid for it. Raises were basically 1-2.5% per year if you were in top 3% of company. Bonuses were gutted , expense reports were scrutinized for every penny and layoffs kicked into full gear with The Smiling Killer. This is the worst thing that possibly could happen to Biogen.
Click to expand...

Sounds like he’ll fit right in at Biogen. Just add in “treat his employees like shit and fuck up everything he touches,” and you’ve got the Biogen leadership mantra. We won’t notice a difference between Viebacher and Michele. Just business as usual at this dysfunctional dumpster fire.
 






anonymous said:
Let's not forget How Viehbacher did a hostile takeover of Gensyme and severely overpaid for it. Raises were basically 1-2.5% per year if you were in top 3% of company. Bonuses were gutted , expense reports were scrutinized for every penny and layoffs kicked into full gear with The Smiling Killer. This is the worst thing that possibly could happen to Biogen.
Click to expand...

Fun fact, BIIB was on the acquisition list but was going to cost too much. Genzyme had a number of 483s that were holding them down so they were more affordable. This was when Sanofi finally realized there was more money and better IP protection in specialty and rare disease. I still remember some Swiss jackass with strategy in his title telling me why Sanofi had no interest in small market and specialty products.

without Genzyme, Sanofi would be even crappier than they are.

So CV gets BIIB in the end anyway.
 


















It kinda seems like complete karma Biogen ended up with this guy.

Consumed by greed and arrogance they priced Aduhelm at like triple what it was worth and engaged in shady back door FDA deals.

This is the price.

15 years ago they were the pride of biotech. Quite the fall. And pride cometh before.
 






anonymous said:
It kinda seems like complete karma Biogen ended up with this guy.

Consumed by greed and arrogance they priced Aduhelm at like triple what it was worth and engaged in shady back door FDA deals.

This is the price.

15 years ago they were the pride of biotech. Quite the fall. And pride cometh before.
Click to expand...

Biogen has pretty much been a joke since Mullen left over a decade ago. Look at the human waste that has cycled through the company.
 


















Top Bottom
Back
Quote